Read Larry Connors' blog – Short Term Trading Strategies
The new features are part of a series of improvements designed to create a significantly enhanced online retail experience for scientists who are increasingly using the Web to inform their purchase decisions and to buy the products they need to conduct their experiments. Transactions processed through this 24/7 online global store offer convenience for customers ordering reagents and other consumable products, and are significantly less expensive to process, compared to purchases made through other channels. Among the enhanced features are:
-- Comprehensive Product Details: Product information has been expanded to include real-time availability and pricing. Comprehensive scientific reference information is also now available for all products, including instructional guides, specifications, and industry protocols and documentation.
-- Self Service: New self-service features eliminate the need to phone customer service or sales reps for daily order management. These capabilities are designed for laboratories and individual end-users to conveniently manage account details and order history online.
-- Enhanced Online Purchasing: New, best-in-class shopping cart features have been added to enable management of multiple carts, provide secured order workflow, and facilitate cart collaboration with other registered users of Invitrogen.com.
-- Streamlined Oligo Design: Genomic researchers can design oligos for tubes and plates more efficiently as a result of new, simplified templates that facilitate easy ordering of multiple sequences at once. This feature includes online guides that walk users through the entire ordering process, including contextual help messages and other assistance.
With more than 1 million visits per month, Invitrogen.com is Invitrogen's primary channel for customer self service and order management. The site is organized around 10 application storefronts, which are designed to support the various ways scientists work, such as cloning, cell culture, drug discovery, and bioproduction. It has earned multiple awards, including the Life Science Industry Awards designation as "Most Useful Website" in 2006, 2007 and 2008, and The Scientist's Readers' Choice Award in 2004. Invitrogen.com brings together leading brands in scientific research, including GIBCO(R), Molecular Probes(R), and Dynal(R), select Applied Biosystems reagents and enzymes for PCR and real-time PCR, and a complete line of Ambion RNA products.
Bernd Brust, Chief Commercial Officer, Life Technologies
"The Web is an important channel in Life Technologies' marketing and demand generation efforts. We've created an online environment for communicating with our customers, who want the flexibility to interact with us when they want, and at whatever level of frequency they choose. We will continue to make significant investments in our total eBusiness strategy, encompassing both Invitrogen.com and Applied Biosystems.com."
Siddhartha C. Kadia, Ph.D., Chief Marketing Officer, Life Technologies
"The new enhancements to Invitrogen.com have been implemented to maintain its distinction as the life science industry's premier online retail destination, featuring the broadest selection of differentiated products from a single source. These changes are driven by feedback from our customers regarding how we could better serve them by tailoring the site to the ways scientists want to research and buy products, making it easier and quicker for them to find exactly what they need to accelerate their research."
About Invitrogen Products
Invitrogen is a leading provider of platform independent, essential life science technologies for disease and drug research, bioproduction and diagnostics. Invitrogen, together with Applied Biosystems -- a global leader in providing innovative instrument systems to accelerate academic and clinical research, drug discovery and development, pathogen detection and forensic DNA analysis -- is part of Life Technologies Corporation, which markets the life science industry's most comprehensive portfolio of solutions for molecular and cell biology. Invitrogen and Applied Biosystems products are used in nearly every major laboratory in the world.
For more information, please visit: http://www.invitrogen.com and www.appliedbiosystems.com.
About Life Technologies
Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com.
Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
Copyright 2009. Life Technologies Corporation. All rights reserved. Invitrogen is a trademark of Life Technologies in the US and/or certain other countries. GIBCO, Molecular Probes, and Dynal are registered trademarks of Invitrogen and Life Technologies.
SOURCE: Life Technologies Corporation
Life Technologies Renaldo Juanso, 650-638-5354 (Media) Public Relations renaldo.juanso@lifetech.com Amanda Clardy, 760-603-7200 (Investors) Corporate and Financial Communications amanda.clardy@lifetech.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
